Metronidazole Dosing for C. difficile Infection
For an initial episode of non-severe C. difficile infection (CDI), metronidazole should only be used when access to vancomycin or fidaxomicin is limited, at a dose of 500 mg orally three times daily for 10 days. 1
Treatment Algorithm Based on Disease Severity
Initial Episode Treatment
Non-severe CDI (WBC ≤15,000 cells/mL and serum creatinine <1.5 mg/dL):
Severe CDI (WBC ≥15,000 cells/mL or serum creatinine >1.5 mg/dL):
Fulminant CDI (hypotension, shock, ileus, or megacolon):
Recurrent CDI Treatment
First recurrence:
Second or subsequent recurrences:
Important Considerations for Metronidazole Use
- Metronidazole is significantly less effective than vancomycin for severe CDI (76% vs 97% cure rate) 2
- Avoid repeated or prolonged courses of metronidazole due to risk of cumulative and potentially irreversible neurotoxicity 1, 4
- When oral administration is not possible, intravenous metronidazole can be given at 500 mg every 8 hours, particularly in fulminant CDI with ileus 1, 3
- Treatment duration may need to be extended to 14 days in patients with delayed response to metronidazole 1
- Metronidazole has poor efficacy for asymptomatic C. difficile carriers and is not recommended for this purpose 5
Monitoring and Follow-up
Monitor for clinical response (resolution of diarrhea, absence of severe abdominal discomfort) 6
Watch for potential metronidazole side effects, particularly with prolonged use:
- Peripheral neuropathy
- Hepatotoxicity
- Metallic taste
- Nausea 4
Testing for cure is not recommended; treat until clinical symptoms resolve 1